OLIGOESTERS COMPOSITIONS AND METHODS OF MAKING AND USING SAME

(19)

(11)

EP 3 504 267 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	16.10.2024 Bulletin 2024/42

(45)	Mention of the grant of the patent:
	21.08.2024 Bulletin 2024/34

(21)	Application number: 17854053.0

(22)	Date of filing: 23.09.2017

(51)

International Patent Classification (IPC):

C08L 9/06^(2006.01)
C08L 93/04^(2006.01)

C09J 193/04^(2006.01)
C09F 1/04^(2006.01)

(52)	Cooperative Patent Classification (CPC):
	C08L 93/04; C09F 1/04; C09J 193/04

(86)	International application number:
	PCT/US2017/053126

(87)	International publication number:
	WO 2018/058005 (29.03.2018 Gazette 2018/13)

(54)	OLIGOESTERS COMPOSITIONS AND METHODS OF MAKING AND USING SAME MIKRORNA-ZUSAMMENSETZUNGEN UND VERFAHREN ZUR HERSTELLUNG UND VERWENDUNG DAVON COMPOSITIONS D'OLIGOESTERS ET PROCÉDÉS DE FABRICATION ET D'UTILISATION ASSOCIÉS

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

23.09.2016 US 201662398723 P

(43)	Date of publication of application:
	03.07.2019 Bulletin 2019/27

(73)	Proprietor: Kraton Chemical, LLC
	Jacksonville, FL 32245 (US)

(72)	Inventors:
	LANGE, Jos, H.M. 1322 CE Almere (NL) SCHAAPMAN, Mark, C. 1322 CE Almere (NL)

(74)	Representative: Henkel & Partner mbB
	Patentanwaltskanzlei, Rechtsanwaltskanzlei Maximiliansplatz 21 80333 München 80333 München (DE)

(56)

References cited: :

EP-A1- 2 012 185
WO-A1-2017/117576
US-A- 3 935 158
US-A1- 2011 048 599
US-A1- 2014 142 334

WO-A1-2015/048402
WO-A2-95/02019
US-A1- 2003 212 201
US-A1- 2013 022 907

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).